Elite Academic Visionary Award
Sidharth Ray
Touro University College of Pharmacy
Sidharth Ray is an academic researcher associated with Touro University College of Pharmacy in the United States, with a stated subject-area focus in pharmacology. The supplied academic profile records 356 documents, 10,089 citations, and an h-index of 47. His listed research record includes work addressing diabetes management, pharmacogenetics, insulin resistance, semaglutide and cardiovascular considerations, transplantation outcomes, and experimental toxicology. These publications provide a basis for considering the breadth and scholarly relevance of his research activity in relation to the Elite Academic Visionary Award.
Abstract
The Elite Academic Visionary Award profile recognizes the scholarly record presented for Sidharth Ray, whose stated academic affiliation is Touro University College of Pharmacy and whose principal subject area is pharmacology. The supplied metrics indicate 356 documents, 10,089 citations, and an h-index of 47. His documented publication portfolio spans pharmacological and biomedical topics including diabetes management, insulin resistance, pharmacogenetics, semaglutide, cardiovascular considerations, transplantation, and toxicology. Recent supplied records include a 2026 article examining etiological approaches to diabetes management and insulin resistance, a 2026 review concerning semaglutide and the heart, and a 2026 registry analysis of kidney transplantation in lithium nephrotoxicity. [1] [2] [3]
Keywords
Keywords: Sidharth Ray, pharmacology, pharmacogenetics, diabetes management, insulin resistance, semaglutide, cardiovascular pharmacology, transplantation, toxicology, pharmaceutical research, academic research, biomedical science, drug effects, clinical research, International Popular Scientist Awards.
Introduction
Pharmacology encompasses the study of drugs, their mechanisms of action, therapeutic applications, adverse effects, and interactions with biological systems. Research at the intersection of pharmacology and clinical medicine can address both therapeutic development and the evaluation of established interventions across diverse disease contexts. The publication records supplied for Sidharth Ray demonstrate involvement in several such areas, including metabolic disease, cardiovascular considerations, renal transplantation, and experimental toxicology.
Research Profile
The supplied profile identifies Sidharth Ray with Touro University College of Pharmacy and places his primary subject area within pharmacology. The stated bibliometric record comprises 356 documents, 10,089 citations, and an h-index of 47. These figures describe the supplied profile at the time of preparation and should be interpreted in the context of the indexing platform, author disambiguation, publication coverage, and the date on which the metrics were retrieved.
Research Contributions
The supplied publications indicate a multidisciplinary research profile within pharmacology and related biomedical fields. The themes represented in the records include metabolic disease, cardiovascular pharmacotherapy, renal transplantation, and toxicological protection.
- Diabetes and insulin resistance: A 2026 article addresses diabetes management through an etiological perspective and discusses minimizing insulin resistance in connection with pharmacogenetics. [1]
- Metabolic and cardiovascular pharmacology: A 2026 publication examines semaglutide and its relationship with cardiovascular considerations, contributing to discussion of the broader clinical context of glucagon-like peptide-1 receptor agonist therapy. [2]
- Transplantation research: A 2026 registry analysis evaluates kidney transplantation for lithium nephrotoxicity and reports on graft and patient survival outcomes. [3]
- Toxicological research: An earlier experimental publication investigated protection against drug- and chemical-induced multiorgan toxicity using an IH636 grape seed proanthocyanidin extract. [4]
Publications
The researcher’s publications span diabetes management, cardiovascular pharmacology, kidney transplantation, and drug-induced organ toxicity. Recent work explores pharmacogenetic approaches to reducing insulin resistance in diabetes, the complex cardiovascular effects of semaglutide, and outcomes of kidney transplantation for lithium nephrotoxicity. Earlier research investigated the protective effects of grape seed proanthocyanidin extract against drug- and chemical-induced multiorgan toxicity, demonstrating a broad research focus on therapeutic strategies and organ protection.
Research Impact
The supplied bibliometric figures of 10,089 citations and an h-index of 47 indicate that the profile has accumulated substantial citation activity across its indexed research output. The stated total of 356 documents further indicates a broad publication record. Such metrics are descriptive indicators of scholarly visibility and citation performance; they do not independently measure methodological quality, clinical effectiveness, societal benefit, or the significance of individual publications.1] [2] [3] The earlier toxicology study illustrates an additional experimental dimension of the supplied publication record. [4]
Award Suitability
For the purposes of the Elite Academic Visionary Award profile, the supplied record provides several documented dimensions for academic recognition: an established publication portfolio, substantial citation activity, a reported h-index of 47, and research spanning pharmacology and related biomedical disciplines. The recent publication record also demonstrates continued engagement with contemporary questions involving diabetes, insulin resistance, pharmacogenetics, semaglutide, cardiovascular considerations, and transplantation. [1] [2] [3]
Conclusion
Sidharth Ray’s supplied academic profile represents a substantial body of pharmacological and biomedical research, with 356 documents, 10,089 citations, and an h-index of 47. The selected publications demonstrate research activity involving diabetes management, pharmacogenetics, insulin resistance, semaglutide and cardiovascular considerations, kidney transplantation, and toxicological protection. [1] [2] [3] [4] Taken together, the supplied information provides a documented academic profile for consideration within the context of the Elite Academic Visionary Award and the International Popular Scientist Awards.
External Links
References
- Ray, Sidhartha D.; He, Lining Liang; Rottersmann, Stratton; Hand, Christina; Di Leo, Maria; Chunilall, Alec; Gray, Ian G.; Siu, Ngo Tsun; Jong, Sonia; Sirois, Nigel, et al. (2026). Shifting the Paradigm in Global Diabetes Management: Beyond Glycohemoglobinism and Toward Etiological Mitigation via Minimizing Insulin Resistance on the Basis of Pharmacogenetics. Diabetology, 7(9), 176.
https://doi.org/10.3390/diabetology7090176
- Khan, Ezaan; Fernandes, Jessica; Gohel, Vishal; Jain, Rihi; Jayne, William; Peck, Colton; Shah, Tara S.; Shah, Radha S.; LaBarge, Judithe; Ray, Sidhartha D., et al. (2026). Semaglutide and the Heart: Focus on Their Love–Hate Relationship. Hearts, 7(3), 22.
https://doi.org/10.3390/hearts7030022
- Cohen, Hannah; Toro, Deric; Zuluaga, Dayanna; Faddoul, Giovanni; Ray, Sidhartha D.; McAfee, Gavin; Ortiz, Alex Chiodo; Gillenwalters, Luke; Islam, Nashitah; Dean, Mary Ellen, et al. (2026). Kidney Transplantation for Lithium Nephrotoxicity is Associated With Noninferior Graft and Patient Survival: A National Donor-Stratified Registry Analysis. Clinical Transplantation.
https://doi.org/10.1111/ctr.70563
- Bagchi, D.; Ray, S. D.; Patel, D.; Bagchi, M. (2001). Protection against drug- and chemical-induced multiorgan toxicity by a novel IH636 grape seed proanthocyanidin extract. Drugs under Experimental and Clinical Research.
https://pubmed.ncbi.nlm.nih.gov/11276828/
- Google Scholar. Academic profile associated with Sidharth Ray, Google Scholar ID 6qkMgcgAAAAJ.
https://scholar.google.com/citations?user=6qkMgcgAAAAJ&hl=en&oi=ao&cstart=0&pagesize=20